Global Insulin Delivery Devices Market Growth 2022-2028
SKU ID :LPI-20420165 | Published Date: 08-Mar-2022 | No. of pages: 128Description
As the global economy mends, the 2021 growth of Insulin Delivery Devices will have significant change from previous year. According to our researcher latest study, the global Insulin Delivery Devices market size is USD million in 2022 from USD 10350 million in 2021, with a change of % between 2021 and 2022. The global Insulin Delivery Devices market size will reach USD 13480 million in 2028, growing at a CAGR of 3.8% over the analysis period.
The United States Insulin Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insulin Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Insulin Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Insulin Delivery Devices players cover Novo Nordisk, Sanofi, BD, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Patients/Homecare
Hospitals & Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
Insulet
MannKind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
The United States Insulin Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insulin Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Insulin Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Insulin Delivery Devices players cover Novo Nordisk, Sanofi, BD, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Patients/Homecare
Hospitals & Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
Insulet
MannKind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
TOC
Tables & Figures
Companies
- PRICE
-
$3660$7320$5490Buy Now